Skip to main content
Figure 4 | Lipids in Health and Disease

Figure 4

From: Are post-treatment low-density lipoprotein subclass pattern analyses potentially misleading?

Figure 4

Mean % change from baseline in non-HDL-C after treatment with ezetimibe added to atorvastatin vs doubling the atorvastatin dose for 6 weeks in the overall population and in subgroups with baseline triglycerides (BL TG) <150 or ≥150 mg/dL. Numbers below bars represent the between treatment difference (95% confidence interval). Overall population, A40 + EZ: n = 225; A80: n = 222; Baseline triglycerides <150 mg/dL, A40 + EZ: n = 136; A80: n = 140; Baseline triglycerides ≥150 mg/dL, A40 + EZ: n = 89; A80: n = 82

Back to article page